Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 159
Filter
1.
Development ; 128(14): 2747-53, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11526080

ABSTRACT

In leaves of the maize tangled1 (tan1) mutant, clusters of bundle sheath (BS)-like cells extend several cells distant from the veins, in association with the single layer of BS cells around the vein. We show that the BS-like cell clusters in tan1 leaves result from the continued division of cells in the procambial/BS cell lineage that do not divide further in wild-type leaves. The ectopic BS-like cells accumulate the BS marker NADP-dependent malic enzyme but not the mesophyll cell marker phosphoenolpyruvate carboxylase, and exhibit thickened walls, suggesting that they differentiate as C4-type BS cells. We propose that bundle sheath cell fate can be conferred on some derivatives of procambial cell divisions in a manner that is heritable through multiple cell divisions and is position-independent.


Subject(s)
Plant Proteins/physiology , Zea mays/cytology , Cell Differentiation , Cell Lineage , Mutagenesis , Plant Leaves/cytology , Plant Leaves/growth & development , Plant Proteins/genetics , Plant Proteins/metabolism , Zea mays/growth & development
2.
Infect Dis Clin North Am ; 15(2): 551-65, x, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11447709

ABSTRACT

Hyposplenism, secondary to splenectomy or disease state, predisposes the host to overwhelming infection with certain bacteria, such as S. pneumoniae. Recognition of the hyposplenic state and preventive measures, including patient education and vaccination, appear to reduce the rate of this highly fatal infection. In addition to considering chemoprophylaxis, a clinician should promptly evaluate or empirically treat all febrile episodes in hyposplenic patients.


Subject(s)
Postoperative Complications/microbiology , Splenic Diseases/complications , Humans , Postoperative Complications/prevention & control , Practice Guidelines as Topic , Sepsis/microbiology , Sepsis/prevention & control , Splenectomy/adverse effects , Vaccination
3.
Nat Rev Mol Cell Biol ; 2(1): 33-9, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11413463

ABSTRACT

Plant cells are surrounded by walls that define their shapes and fix their positions with tissues. Consequently, establishment of a plant's cellular framework during development depends largely on the positions in which new walls are formed during cytokinesis. Experiments using various approaches are now building on classical studies to shed light on the mechanisms underlying the spatial control of cytokinesis.


Subject(s)
Plant Cells , Cell Division/genetics , Cell Polarity , Cell Wall/ultrastructure , Cytoskeleton/ultrastructure , Genes, Plant , Models, Biological , Mutation , Plants/genetics , Zea mays/cytology , Zea mays/genetics
4.
Avian Dis ; 45(1): 136-43, 2001.
Article in English | MEDLINE | ID: mdl-11332474

ABSTRACT

The nucleocapsid (N) gene of turkey coronavirus (TCV) was amplified by reverse transcriptase-polymerase chain reaction, cloned, and expressed in the baculovirus expression system. A recombinant baculovirus containing the TCV N gene (rBTCV/N) was identified by polymerase chain reaction and expression of TCV N protein as determined by western immunoblot analysis. Two TCV-specific proteins, 52 and 43 kDa, were expressed by rBTCV/N; one of these proteins, p52, was comparable in size to native TCV N protein. Baculovirus-expressed N proteins were used as antigen in an indirect enzyme-linked immunosorbent assay (ELISA) for detection of TCV-specific antibodies. The ELISA detected antibodies specific for TCV and infectious bronchitis virus, a closely related avian coronavirus, but did not detect antibodies specific for other avian viruses (avian influenza, avian reovirus, avian paramyxovirus 3, avian adenovirus 1, or Newcastle disease virus). These findings indicate that baculovirus-expressed TCV N protein is a suitable source of antigen for ELISA-based detection of TCV-specific antibodies in turkeys.


Subject(s)
Baculoviridae/metabolism , Nucleocapsid Proteins , Nucleocapsid/biosynthesis , Turkeys/virology , Animals , Coronavirus Nucleocapsid Proteins , Enteritis/veterinary , Enteritis/virology , Enzyme-Linked Immunosorbent Assay/veterinary , North Carolina , Nucleocapsid/genetics , Poultry Diseases/virology , Reverse Transcriptase Polymerase Chain Reaction/veterinary
5.
Med Clin North Am ; 85(1): 115-23, vii, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11190347

ABSTRACT

The use of antimicrobial agents (i.e., penicillins, cephalosporins, macrolides, aminoglycosides, tetracyclines, quinolones) have continued to grow at an astounding rate. Centers for Disease Control and Prevention estimates are of some 150 million prescriptions annually in the United States, amounting to some 50 millions pounds of antibiotics annually being used in the United States with some 15 to 17 million pounds being used in livestock and agriculture alone. These large numbers serve as indicators for caution and concern. Most oral antibiotics are prescribed for respiratory tract infections, more than half of which are probably viral, for which antimicrobials are not necessary. This overprescribing is noted at a time when increasing antimicrobial resistance is being recognized in hospital settings as well as in the community. The dilemma for the practitioner is to be able to use antibiotics efficaciously and prevent overusage and overprescribing.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Communicable Diseases/drug therapy , Drug Resistance, Multiple , Administration, Oral , Anti-Bacterial Agents/pharmacology , Communicable Diseases/microbiology , Humans , Microbial Sensitivity Tests , Sensitivity and Specificity , Treatment Outcome
6.
J Nucl Med ; 42(2): 292-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11216529

ABSTRACT

UNLABELLED: The alteration of 99mTc-labeled diethylenetriaminepentaacetic acid (DTPA) transalveolar clearance in an initial phase of radiation lung injury was experimentally investigated. METHODS: Fourteen dogs were irradiated to the hemithorax with a single dose of 20 Gy. A DTPA radioaerosol study was performed before irradiation and on day 12 after irradiation. On day 14, the DTPA study was repeated again, with seven animals undergoing the study after inhalation of an aerosolized synthetic surfactant. The penetration index (P.I.) and clearance half-time (T(1/2)) of DTPA were measured in each lung. To evaluate the changes in lung surfactant after irradiation, alveolar lipids were stained in the resected lungs (n = 14), and the amounts of alveolar surfactant phospholipid and protein were measured by a bronchoalveolar lavage study in another six irradiated dogs. RESULTS: In all of the 14 irradiated animals, DTPA radioaerosol distributed uniformly throughout the lungs without significant changes in P.I. The T(1/2) values in irradiated lungs were significantly prolonged compared with the matched baseline values and those in nonirradiated lungs (P < 0.05 and 0.001, respectively). The aerosolized synthetic surfactant retarded the DTPA clearance both in the irradiated and in the nonirradiated lungs (P < 0.001) without significant changes in P.I. The histologic and bronchoalveolar lavage studies revealed an increase of alveolar surfactant materials in the irradiated lungs without substantial histologic changes in the alveolar structures. CONCLUSION: DTPA transalveolar clearance was retarded soon after irradiation. Increased alveolar surfactant may be partly responsible for this retarded DTPA clearance because the aerosolized synthetic surfactant also prolonged the clearance in nonirradiated lungs. A DTPA clearance test is sensitive for the early detection of radiation lung injury and seems helpful for clarifying the association of epithelial integrity changes and lung surfactant in radiation lung injury.


Subject(s)
Lung/radiation effects , Phosphorylcholine , Pulmonary Alveoli/metabolism , Radiation Injuries, Experimental/metabolism , Radiopharmaceuticals/pharmacokinetics , Technetium Tc 99m Pentetate/pharmacokinetics , Administration, Inhalation , Aerosols , Animals , Dogs , Drug Combinations , Fatty Alcohols/administration & dosage , Fatty Alcohols/pharmacology , Lipids/analysis , Lung/diagnostic imaging , Polyethylene Glycols/administration & dosage , Polyethylene Glycols/pharmacology , Pulmonary Alveoli/radiation effects , Pulmonary Surfactants/administration & dosage , Pulmonary Surfactants/pharmacology , Pulmonary Surfactants/radiation effects , Radiation Dosage , Radiation Injuries, Experimental/diagnostic imaging , Radiation Injuries, Experimental/pathology , Radionuclide Imaging , Radiopharmaceuticals/administration & dosage , Technetium Tc 99m Pentetate/administration & dosage
7.
Acad Med ; 76(2): 181-3, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11158842

ABSTRACT

PURPOSE: To determine the amount and type of training U.S. internal medicine residents receive in providing home care to patients. METHOD: A four-item questionnaire was developed and sent to the program directors of all accredited internal medicine residencies in the United States (n = 397) to assess the amounts and types of training (didactic sessions or lectures, house calls, or both) internal medicine residents receive in providing home care. Demographic information about the residency programs was also collected and analyzed. RESULTS: A total of 312 (78.6%) of the program directors responded. Sixty-eight percent of their programs included instruction in home care consisting of house calls, lectures, or both. Fewer than half of the responding programs offered any lecture in home care in their curricula, and only 25% of them included a mandatory house-call experience for trainees. Residency programs that had primary care tracks were more likely than were other programs to include either of these experiences in their curricula. CONCLUSIONS: Most internal medicine residents receive limited training in home care. As a consequence, future internists may be inadequately prepared to meet the needs of their patients, particularly as the population ages.


Subject(s)
Home Care Services , Internal Medicine/education , Internship and Residency , Curriculum , Home Care Services/standards , House Calls , Surveys and Questionnaires , United States
8.
J Cell Biol ; 152(1): 231-6, 2001 Jan 08.
Article in English | MEDLINE | ID: mdl-11149933

ABSTRACT

Spatial control of cytokinesis in plant cells depends on guidance of the cytokinetic apparatus, the phragmoplast, to a cortical "division site" established before mitosis. Previously, we showed that the Tangled1 (Tan1) gene of maize is required for this process during maize leaf development (Cleary, A.L., and L.G. Smith. 1998. Plant Cell. 10:1875-1888.). Here, we show that the Tan1 gene is expressed in dividing cells and encodes a highly basic protein that can directly bind to microtubules (MTs). Moreover, proteins recognized by anti-TAN1 antibodies are preferentially associated with the MT-containing cytoskeletal structures that are misoriented in dividing cells of tan1 mutants. These results suggest that TAN1 protein participates in the orientation of cytoskeletal structures in dividing cells through an association with MTs.


Subject(s)
Microtubule-Associated Proteins/physiology , Plant Proteins/physiology , Zea mays/physiology , Cell Division/physiology , Cloning, Molecular , Cytoskeleton/metabolism , DNA Transposable Elements , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Plant Proteins/genetics , Plant Proteins/metabolism
9.
J Clin Microbiol ; 38(12): 4523-6, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11101590

ABSTRACT

A coronavirus was isolated from feces of a diarrheic foal and serially propagated in human rectal adenocarcinoma (HRT-18) cells. Antigenic and genomic characterizations of the virus (isolate NC99) were based on serological comparison with other avian and mammalian coronaviruses and sequence analysis of the nucleocapsid (N) protein gene. Indirect fluorescent-antibody assay procedures and virus neutralization assays demonstrated a close antigenic relationship with bovine coronavirus (BCV) and porcine hemagglutinating encephalomyelitis virus (mammalian group 2 coronaviruses). Using previously described BCV primers, the N protein gene of isolate NC99 was amplified by a reverse transcriptase PCR (RT-PCR) procedure. The RT-PCR product was cloned into pUC19 and sequenced; the complete N protein of NC99 (446 amino acids) was then compared with published N protein sequences of other avian and mammalian coronaviruses. A high degree of identity (89.0 to 90.1%) was observed between the N protein sequence of NC99 and published sequences of BCV (Mebus and F15 strains) and human coronavirus (strain OC43); only limited identity (<25%) was observed with group 1 and group 3 coronaviruses. Based on these findings, the virus has been tentatively identified as equine coronavirus (ECV). ECV NC99 was determined to have close antigenic and/or genetic relationships with mammalian group 2 coronaviruses, thus identifying it as a member of this coronavirus antigenic group.


Subject(s)
Coronavirus OC43, Human , Coronavirus/isolation & purification , Diarrhea/veterinary , Horse Diseases/virology , Amino Acid Sequence , Animals , Capsid/genetics , Coronavirus/classification , Diarrhea/virology , Feces/virology , Horses , Humans , Microscopy, Electron , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction
10.
J Clin Oncol ; 18(23): 3904-11, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11099319

ABSTRACT

PURPOSE: To determine the effect of radiotherapy dose on prostate cancer patient outcome and biopsy positivity in a phase III trial. PATIENTS AND METHODS: A total of 305 stage T1 through T3 patients were randomized to receive 70 Gy or 78 Gy of external-beam radiotherapy between 1993 and 1998. Of these, 301 were assessable; stratification was based on pretreatment prostate-specific antigen level (PSA). Dose was prescribed to the isocenter at 2 Gy per fraction. All patients underwent planning pelvic computed tomography scan to confirm prostate position. Treatment failure was defined as an increasing PSA on three consecutive follow-up visits or the initiation of salvage treatment. Median follow-up was 40 months. RESULTS: One hundred fifty patients were randomized to the 70-Gy arm and 151 to the 78-Gy arm. The difference in freedom from biochemical and/or disease failure (FFF) rates of 69% and 79% for the 70-Gy and 78-Gy groups, respectively, at 5 years was marginally significant (log-rank P: =.058). Multiple-covariate Cox proportional hazards regression showed that the study randomization was an independent correlate of FFF, along with pretreatment PSA, Gleason score, and stage. The patients who benefited most from the 8-Gy dose escalation were those with a pretreatment PSA of more than 10 ng/mL; 5-year FFF rates were 48% and 75% (P: =.011) for the 70-Gy and 78-Gy arms, respectively. There was no difference between the arms ( approximately 80% 5-year FFF) when the pretreatment PSA was < or = 10 ng/mL. CONCLUSION: A modest dose increase of 8 Gy using conformal radiotherapy resulted in a substantial improvement in prostate cancer FFF rates for patients with a pretreatment PSA of more than 10 ng/mL. These findings document that local persistence of prostate cancer in intermediate- to high-risk patients is a major problem when doses of 70 Gy or less are used.


Subject(s)
Prostatic Neoplasms/radiotherapy , Disease-Free Survival , Dose-Response Relationship, Radiation , Humans , Male , Multivariate Analysis , Neoplasm Staging , Palpation , Proportional Hazards Models , Prospective Studies , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/immunology , Radiotherapy Dosage , Survival Analysis , Ultrasonography
11.
Antimicrob Agents Chemother ; 44(12): 3408-13, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11083648

ABSTRACT

This randomized, double-blind, multicenter trial compared the efficacy and safety of linezolid, an oxazolidinone, with those of oxacillin-dicloxacillin in patients with complicated skin and soft tissue infections. A total of 826 hospitalized adult patients were randomized to receive linezolid (600 mg intravenously [i.v.]) every 12 h or oxacillin (2 g i.v.) every 6 h; following sufficient clinical improvement, patients were switched to the respective oral agents (linezolid [600 mg orally] every 12 h or dicloxacillin [500 mg orally] every 6 hours). Primary efficacy variables were clinical cure rates in both the intent-to-treat (ITT) population and clinically evaluable (CE) patients and microbiological success rate in microbiologically evaluable (ME) patients. Safety and tolerability were evaluated in the ITT population. Demographics and baseline characteristics were similar across treatment groups in the 819 ITT patients. In the ITT population, the clinical cure rates were 69.8 and 64.9% in the linezolid and oxacillin-dicloxacillin groups, respectively (P = 0.141; 95% confidence interval -1.58 to 11. 25). In 298 CE linezolid-treated patients, the clinical cure rate was 88.6%, compared with a cure rate of 85.8% in 302 CE patients who received oxacillin-dicloxacillin. In 143 ME linezolid-treated patients, the microbiological success rate was 88.1%, compared with a success rate of 86.1% in 151 ME patients who received oxacillin-dicloxacillin. Both agents were well tolerated; most adverse events were of mild-to-moderate intensity. No serious drug-related adverse events were reported in the linezolid group. These data support the use of linezolid for the treatment of adults with complicated skin and soft tissue infections.


Subject(s)
Acetamides/therapeutic use , Dicloxacillin/therapeutic use , Oxacillin/therapeutic use , Oxazolidinones/therapeutic use , Skin Diseases, Bacterial/drug therapy , Soft Tissue Infections/drug therapy , Acetamides/adverse effects , Anti-Infective Agents/adverse effects , Anti-Infective Agents/therapeutic use , Dicloxacillin/adverse effects , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Linezolid , Male , Middle Aged , Oxacillin/adverse effects , Oxazolidinones/adverse effects , Penicillins/adverse effects , Penicillins/therapeutic use , Treatment Outcome
12.
AIDS Res Hum Retroviruses ; 16(14): 1345-55, 2000 Sep 20.
Article in English | MEDLINE | ID: mdl-11018854

ABSTRACT

A double-blind, placebo-controlled trial of efficacy and safety of thalidomide in AIDS-associated wasting was carried out. Ninety-nine of 103 male patients had at least one on-study measurement (intent-to-treat [ITT] cohort). Patients were randomized to thalidomide at 100 mg/day (T100) or 200 mg/day (T200), or placebo for 8 weeks. By ITT analysis, the mean change in body weight of the placebo, T100, and T200 treatment groups was 0.3 kg (0.4%), 2.0 kg (3.0%), and 0.9 kg (1.4%), respectively (p = 0.021 for T100 versus placebo; p = 0.53 for T200 versus placebo). Of the 64 patients who completed the 8 weeks of study treatment, significant weight gain was observed in both the T100 group (2.2 kg, [33%]; p = 0.008 versus placebo) and the T200 group (1.5 kg [2.5%]; p = 0.019 versus placebo). Approximately half the weight gain was fat-free mass (bioimpedance analysis). Patients in the T100 or T200 groups had no significant change in CD4+ cell counts, neutrophil counts, or TNF-alpha levels, compared with placebo. HIV viral load measured as log10 copies/ml decreased by a median of 0.07 in the placebo group, and increased by a median of 0.29 (T100 group) and 0.23 (T200 group) (p = 0.024 andp = 0.018 versus placebo, respectively). Thalidomide therapy was associated with mild to moderate rashes and fevers, but not peripheral neuropathy. Although the anabolic benefits of high-dose thalidomide are limited by drug intolerance, 8 weeks of low-dose thalidomide results in significant weight gain in patients with AIDS-associated wasting.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Wasting Syndrome/drug therapy , Thalidomide/therapeutic use , Adult , Body Composition , Body Weight , CD4 Lymphocyte Count , Double-Blind Method , Energy Intake , Female , HIV-1/isolation & purification , Humans , Male , Middle Aged , Treatment Outcome , Viral Load
13.
Curr Biol ; 10(19): 1229-32, 2000 Oct 05.
Article in English | MEDLINE | ID: mdl-11050395

ABSTRACT

Asymmetric cell divisions occur repeatedly during plant development, but the mechanisms by which daughter cells are directed to adopt different fates are not well understood [1,2]. Previous studies have demonstrated roles for positional information in specification of daughter cell fates following asymmetric divisions in the embryo [3] and root [4]. Unequally inherited cytoplasmic determinants have also been proposed to specify daughter cell fates after some asymmetric cell divisions in plants [1,2,5], but direct evidence is lacking. Here we investigate the requirements for specification of stomatal subsidiary cell fate in the maize leaf by analyzing four mutants disrupting the asymmetric divisions of subsidiary mother cells (SMCs). We show that subsidiary cell fate does not depend on proper localization of the new cell wall during the SMC division, and is not specified by positional information acting on daughter cells after completion of the division. Instead, our data suggest that specification of subsidiary cell fate depends on polarization of SMCs and on inheritance of the appropriate daughter nucleus. We thus provide evidence of a role for unequal inheritance of an intracellular determinant in specification of cell fate after an asymmetric plant cell division.


Subject(s)
Cell Division , Plant Leaves/cytology , Zea mays/cytology , Cell Lineage , Cell Polarity , Mutation , Zea mays/genetics
14.
Avian Dis ; 44(3): 624-31, 2000.
Article in English | MEDLINE | ID: mdl-11007010

ABSTRACT

A reverse transcriptase-polymerase chain reaction (RT-PCR) procedure and two monoclonal antibody (MAb)-based immunohistochemical procedures were developed for detection of turkey coronavirus (TCV) in tissues and intestinal contents/dropping samples. The RT-PCR, MAb-based fluorescent antibody (FA), and MAb-based immunoperoxidase (IP) procedures were compared with virus isolation (VI) for detection of TCV in experimentally infected turkeys. TCV was detected in experimentally infected turkeys as early as day 1 postexposure (PE) by each of the four detection procedures. TCV was detected as late as day 35 PE by FA or IP and days 42 and 49 PE by VI and RT-PCR, respectively. With VI as a reference, sensitivity and specificity of RT-PCR were 93% and 92%, respectively; specificity of both FA and IP was 96%, and sensitivities were 69% and 61%, respectively. Each of the examined procedures was highly specific, but the RT-PCR procedure was also highly sensitive. These findings demonstrate the utility of both immunohistochemistry and RT-PCR for detection of TCV. In addition, the findings indicate that RT-PCR is a highly sensitive and specific alternative to conventional diagnostic procedures.


Subject(s)
Coronavirus, Turkey/isolation & purification , Enteritis, Transmissible, of Turkeys/diagnosis , Animals , Antibodies, Monoclonal , Cell Line , Fluorescent Antibody Technique , Immunoenzyme Techniques , Immunohistochemistry/methods , Intestinal Mucosa/virology , Reverse Transcriptase Polymerase Chain Reaction , Turkeys
15.
Int J Radiat Oncol Biol Phys ; 48(2): 507-12, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10974469

ABSTRACT

PURPOSE: To characterize the relationship of radiotherapy dose to prostate cancer patient outcome, with an emphasis on the influence of pretreatment prognostic variables. METHODS AND MATERIALS: The 1127 Stage T1-T4 prostate cancer patients examined were treated consecutively with definitive external beam radiotherapy at the University of Texas-M.D. Anderson Cancer Center from 1987 to 1997. All had a pretreatment prostate-specific antigen (PSA) level. Treatment failure was defined as two consecutive PSA elevations on follow-up. There were 994 patients treated with a four-field box throughout to 60-70 Gy after a small reduction at 46 Gy and 161 treated with a six-field conformal boost after 46 Gy to 74-78 Gy. No patient received neoadjuvant or adjuvant androgen ablation. Median follow-up was 51.8 months. RESULTS: Patients were divided into three radiotherapy dose groups consisting of 67-77 Gy (n = 495), and >77 Gy (n = 132). Relative to other prognostic factors, there were fewer patients treated to the highest dose level with a pretreatment PSA (PSAB) 20 ng/ml, Stage T3/T4 disease, or a Gleason score of 2-6. Actuarial 4-year freedom from biochemical failure (bNED) rates for the entire cohort were 54%, 71%, and 77% (p < 0.0001) for the low-, intermediate-, and high-dose groups. PSAB, palpable stage, and Gleason score were also highly significant. In Cox proportional hazards regression, dose (p < 0. 0001 as a continuous or categorical variable) was an independent predictor of bNED, as were the other prognostic factors. Pairwise univariate comparisons showed that an increase in dose from 67-77 Gy was associated with improved bNED rates for all PSAB (10), stage (T1/T2 and T3/T4), and Gleason score (2-6 and 7-10) subgroups tested. In contrast, the only prognostic group that benefited from raising dose from >67-77 Gy to >77 Gy was patients with a PSAB >10 ng/ml; although trends were noted for Stage T1/T2 and Gleason 2-6 patients. Patients with the combined features of a PSAB >10 ng/ml and Stage T1/T2 disease had 4-year bNED rates of 61% and 93% at the intermediate- and high-dose levels. A strongly significant linear association between dose (60-78 Gy) and 4-year actuarial bNED was demonstrated for patients with these intermediate-risk features. CONCLUSION: Prostate cancer dose response to external beam radiotherapy should be considered in the context of pretreatment prognostic factors. Our data indicate that, for favorable patients with a PSAB of 67-77 Gy provide the same rate of control as higher doses. However, longer follow-up may reveal a benefit to dose escalation >77 Gy, even in this favorable subset. Substantial and clinically relevant enhancements in bNED were seen at all dose levels for moderate-risk patients, such as those having a PSAB >10 ng/ml and Stage T1/T2 disease. Sustained bNED was not realized for high-risk patients, even using 78 Gy; these patients may be best treated with higher doses, whole pelvic irradiation, and/or androgen ablation plus radiation.


Subject(s)
Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/radiotherapy , Aged , Aged, 80 and over , Analysis of Variance , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Staging , Proportional Hazards Models , Prostatic Neoplasms/pathology , Radiotherapy Dosage , Treatment Failure
16.
Avian Dis ; 44(1): 105-13, 2000.
Article in English | MEDLINE | ID: mdl-10737650

ABSTRACT

Six-day-old turkeys were inoculated with turkey coronavirus (TCV) and an enteropathogenic Escherichia coli (EPEC) (isolate R98/5) that were isolated from poult enteritis and mortality syndrome (PEMS)-affected turkeys. Turkeys inoculated with only R98/5 did not develop clinically apparent disease, and only mild disease and moderate growth depression were observed in turkeys inoculated with only TCV. Turkeys dually inoculated with TCV and R98/5 developed severe enteritis with high mortality (38/48, 79%) and marked growth depression. R98/5 infection resulted in attaching/effacing (AE) intestinal lesions characteristic of EPEC: adherence of bacterial microcolonies to intestinal epithelium with degeneration and necrosis of epithelium at sites of bacterial attachment. AE lesions were more extensive and were detected for a prolonged duration in dually inoculated turkeys compared with turkeys inoculated with only R98/5. An apparent synergistic effect in dually inoculated turkeys was indicated by increased mortality, enhanced growth depression, and enhanced AE lesion development. The results suggest that TCV promoted intestinal colonization by R98/5; however, R98/5 did not appear to alter TCV infection. The present study provides a possible etiologic explanation for PEMS.


Subject(s)
Enteritis, Transmissible, of Turkeys/complications , Escherichia coli Infections/veterinary , Escherichia coli/pathogenicity , Growth Disorders/veterinary , Poultry Diseases/etiology , Animals , Bacterial Adhesion , Enteritis, Transmissible, of Turkeys/pathology , Escherichia coli Infections/complications , Escherichia coli Infections/pathology , Growth Disorders/etiology , Growth Disorders/pathology , Poultry Diseases/pathology , Turkeys , Weight Gain
17.
Curr Opin Plant Biol ; 2(6): 447-53, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10607656

ABSTRACT

Plant cells divide in two by constructing a new cell wall (cell plate) between daughter nuclei after mitosis. Golgi-derived vesicles are transported to the equator of a cytoskeletal structure called a phragmoplast, where they fuse together to form the cell plate. Orientation of new cell walls involves actindependent guidance of phragmoplasts and associated cell plates to cortical sites established prior to mitosis. Recent work has provided new insights into how actin filaments and other proteins in the phragmoplast and cell plate contribute to cytokinesis. Newly discovered mutations have identified a variety of genes required for cytokinesis or its spatial regulation.


Subject(s)
Cell Division/physiology , Plants/metabolism , Cell Division/genetics , Microtubules/metabolism , Plant Cells , Plants/genetics
18.
Virus Res ; 65(2): 187-93, 1999 Dec 15.
Article in English | MEDLINE | ID: mdl-10581391

ABSTRACT

The 3' end of the turkey coronavirus (TCV) genome (1740 bases) including the nucleocapsid (N) gene and 3' untranslated region (UTR) were sequenced and compared with published sequences of other avian and mammalian coronaviruses. The deduced sequence of the TCV N protein was determined to be 409 amino acids with a molecular mass of approximately 45 kDa. The TCV N protein was identical in size and had greater than 90% amino acid identity with published N protein sequences of infectious bronchitis virus (IBV); less than 21% identity was observed with N proteins of bovine coronavirus and transmissible gastroenteritis virus. The 3' UTR showed some variation among the three TCV strains examined, with two TCV strains, Minnesota and Indiana, containing 153 base segments which are not present in the NC95 strain. Nucleotide sequence identity between the 3' UTRs of TCV and IBV was greater than 78%. Similarities in both size and sequence of TCV and IBV N proteins and 3' UTRs provide additional evidence that these avian coronaviruses are closely related.


Subject(s)
Coronavirus, Turkey/genetics , Infectious bronchitis virus/genetics , Nucleocapsid Proteins , Nucleocapsid/genetics , 3' Untranslated Regions , Amino Acid Sequence , Animals , Base Sequence , Cattle , Coronavirus Nucleocapsid Proteins , DNA, Viral/analysis , Infectious bronchitis virus/classification , Molecular Sequence Data , Nucleocapsid/classification , Sequence Alignment , Turkeys
19.
J Gen Intern Med ; 14(8): 518, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10491240
20.
Development ; 126(20): 4623-33, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10498696

ABSTRACT

In plant cells, cytokinesis depends on a cytoskeletal structure called a phragmoplast, which directs the formation of a new cell wall between daughter nuclei after mitosis. The orientation of cell division depends on guidance of the phragmoplast during cytokinesis to a cortical site marked throughout prophase by another cytoskeletal structure called a preprophase band. Asymmetrically dividing cells become polarized and form asymmetric preprophase bands prior to mitosis; phragmoplasts are subsequently guided to these asymmetric cortical sites to form daughter cells of different shapes and/or sizes. Here we describe two new recessive mutations, discordia1 (dcd1) and discordia2 (dcd2), which disrupt the spatial regulation of cytokinesis during asymmetric cell divisions. Both mutations disrupt four classes of asymmetric cell divisions during the development of the maize leaf epidermis, without affecting the symmetric divisions through which most epidermal cells arise. The effects of dcd mutations on asymmetric cell division can be mimicked by cytochalasin D treatment, and divisions affected by dcd1 are hypersensitive to the effects of cytochalasin D. Analysis of actin and microtubule organization in these mutants showed no effect of either mutation on cell polarity, or on formation and localization of preprophase bands and spindles. In mutant cells, phragmoplasts in asymmetrically dividing cells are structurally normal and are initiated in the correct location, but often fail to move to the position formerly occupied by the preprophase band. We propose that dcd mutations disrupt an actin-dependent process necessary for the guidance of phragmoplasts during cytokinesis in asymmetrically dividing cells.


Subject(s)
Genes, Plant , Mutation , Zea mays/growth & development , Zea mays/genetics , Actins/metabolism , Cell Division/drug effects , Cell Division/genetics , Cytochalasin D/pharmacology , Cytoskeleton/metabolism , Genes, Recessive , Phenotype , Plant Leaves/cytology , Plant Leaves/growth & development , Plant Leaves/metabolism , Zea mays/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...